10-Q: Allied Corp. Reports Q3 2024 Results with Revenue Growth but Continued Losses

Allied Corp. reported a revenue increase in Q3 2024, but also a net loss and a working capital deficit, raising concerns about its ability to continue as a going concern.

Summary

• Allied Corp. reported a net loss of $2,593,922 for the nine months ended May 31, 2024.
• The company generated revenue of $96,180 for the nine-month period, compared to $69,625 in the same period last year.
• The company's gross margin was $72,513 for the nine-month period, compared to $43,667 in the same period last year.
• Operating expenses totaled $2,384,575 for the nine-month period, a decrease from $5,291,850 in the same period last year.
• The company has a working capital deficit of $9,083,174 as of May 31, 2024.
• The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.
• The company intends to finance operations through equity sales, debt financing, and related party loans.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive developments in revenue and cost control, but significant concerns about the company's financial stability and ability to continue as a going concern. The high level of debt and ongoing legal issues further contribute to a negative sentiment.

Positives

• The company experienced a significant increase in revenue for both the three and nine month periods ending May 31, 2024.
• The company's gross margin improved for both the three and nine month periods ending May 31, 2024.
• Total expenses decreased significantly for both the three and nine month periods ending May 31, 2024, primarily due to a reduction in consulting fees.

Negatives

• The company continues to operate at a net loss, with a loss of $2,593,922 for the nine months ended May 31, 2024.
• The company has a substantial working capital deficit of $9,083,174 as of May 31, 2024.
• The company's ability to continue as a going concern is dependent on raising sufficient financing.
• The company has a significant amount of debt in the form of secured convertible notes payable, totaling $3,774,891.

Risks

• The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing.
• The company has a significant working capital deficit, which raises concerns about its short-term financial stability.
• The company is exposed to risks related to the cannabis industry, including regulatory changes and enforcement policies.
• The company is involved in ongoing legal proceedings related to a land lease and building ownership in Nevada.
• The company's convertible notes are secured by a lien on all of its assets, which could pose a risk to shareholders.

Future Outlook

The company's ability to continue as a going concern is dependent on its ability to raise sufficient financing to develop a profitable business. Management intends on financing its operations and future development activities largely from the sale of equity securities and debt financing with some additional funding from other traditional financing sources, including related party loans until such time that funds provided by future planned operations are sufficient to fund working capital requirements.

Management Comments

• Our management team believes that having control over our supply chain should enable us to provide a consistent, rolling-harvest supply to the global cannabis community.
• Given the average cost of production in North America being approximately $1.00 to $2.00 per gram, we believe our anticipated direct agricultural cost of raw flower to be in the range of $0.05 $0.075 per gram.
• Allied Corps commitment to building and maintaining strong relationships with its partners and customers around the world has been a driving force behind its recent successes.

Industry Context

The company operates in the medical cannabis industry, which is subject to evolving regulations and market conditions. The company's focus on low-cost production in Colombia is a strategy to gain a competitive advantage in the global market. The company's ability to access capital may be hindered by the fact that cannabis remains illegal under U.S. federal law.

Comparison to Industry Standards

• The company's reported cost of production of $0.05-$0.075 per gram is significantly lower than the average cost of $1.00-$2.00 per gram in North America, suggesting a potential competitive advantage.
• The company's revenue of $96,180 for the nine-month period is relatively low compared to established cannabis companies, indicating that it is still in the early stages of commercialization.
• The company's net loss of $2,593,922 for the nine-month period is not uncommon for early-stage cannabis companies, but the substantial working capital deficit of $9,083,174 raises concerns about its financial stability.
• The company's reliance on convertible notes and equity financing is typical for companies in the cannabis industry, but the high level of debt and the security interest on all assets could be a concern for investors.

Legal Proceedings

• The company is involved in legal proceedings related to a land lease and building ownership in Nevada.
• The company filed a complaint in the Eighth Judicial District Court in Clark County, Nevada seeking injunctive relief to terminate a trustees sale or alternatively obtain money damages.
• The company filed a lis pendens against the property to reflect this complaint and to protect its interests in the building.
• The company filed suit, seeking a declaration of the company's ownership of the buildings as the buildings were personal property and not a part of the real property.

Related Party Transactions

• The company shares certain administrative resources with companies related by common management and directors.
• The company has amounts due to related parties totaling $826,139 as of May 31, 2024.
• The Chief Executive Officer and the Chief Operating Officer each forgave $75,336 of accrued consulting fees for a total of $150,672, which was recorded as a contribution to the company's equity.

Stakeholder Impact

• Shareholders are at risk due to the company's financial instability and dependence on raising additional capital.
• Employees may be affected by potential cost-cutting measures or operational changes.
• Customers may be impacted by the company's ability to deliver products and services.
• Creditors are at risk due to the company's high level of debt and working capital deficit.
• Suppliers may be affected by the company's ability to pay for goods and services.

Next Steps

• The company needs to raise significant additional capital to fund its operations and future development.
• The company needs to resolve the ongoing legal proceedings related to the land lease and building ownership in Nevada.
• The company needs to continue to develop its cannabis business and expand its operations in Colombia.
• The company needs to manage its debt and improve its financial stability.

Key Dates

Keywords

cannabis, medical cannabis, financial results, revenue, net loss, working capital, convertible notes, equity financing, Colombia, going concern